{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:59:25Z","timestamp":1794315565590,"version":"4.9.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970425"],"award-info":[{"award-number":["81970425"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Advanced atherosclerotic lesions and vascular calcification substantially increase the risk of cardiovascular events. However, effective strategies for preventing or treating advanced atherosclerosis and calcification are currently lacking. This study investigated the efficacy of DT-109 (Gly-Gly-Leu) in attenuating atherosclerosis and calcification in nonhuman primates, exploring its broader therapeutic potential. In this study, twenty male cynomolgus monkeys were administered a cholesterol-rich diet <jats:italic>ad libitum<\/jats:italic> for 10 months. Then, the animals were treated either orally with DT-109 (150\u2009mg\/kg\/day) or a vehicle (H<jats:sub>2<\/jats:sub>O) for 5 months while continuing on the same diet. Plasma lipid levels were measured monthly and at the end of the experiment, pathological examinations of the aortas and coronary arteries and RNA sequencing of the coronary arteries were performed. To explore possible molecular mechanisms, the effects of DT-109 on smooth muscle cells (SMCs) were examined in vitro. We found that DT-109 administration significantly suppressed atherosclerotic lesion formation in both the aorta and coronary arteries. Pathological examinations revealed that DT-109 treatment reduced lesional macrophage content and calcification. RNA sequencing analysis showed that DT-109 treatment significantly downregulated the pro-inflammatory factors <jats:italic>NLRP3<\/jats:italic>, <jats:italic>AIM2<\/jats:italic>, and <jats:italic>CASP1<\/jats:italic>, the oxidative stress factors <jats:italic>NCF2<\/jats:italic> and <jats:italic>NCF4<\/jats:italic>, and the osteogenic factors <jats:italic>RUNX2<\/jats:italic>, <jats:italic>COL1A1<\/jats:italic>, <jats:italic>MMP2<\/jats:italic>, and <jats:italic>MMP9<\/jats:italic>, while simultaneously upregulating the expression of the SMCs contraction markers <jats:italic>ACTA2<\/jats:italic>, <jats:italic>CNN1<\/jats:italic>, and <jats:italic>TAGLN<\/jats:italic>. Furthermore, DT-109 inhibited SMC calcification and NLRP3 inflammasome activation in vitro. These results demonstrate that DT-109 effectively suppresses both atherosclerosis and calcification. These findings, in conjunction with insights from our previous studies, position DT-109 as a novel multifaceted therapeutic agent for cardiovascular diseases.<\/jats:p>","DOI":"10.1038\/s41392-025-02201-2","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T04:16:58Z","timestamp":1743999418000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Tripeptide DT-109 (Gly-Gly-Leu) attenuates atherosclerosis and vascular calcification in nonhuman primates"],"prefix":"10.1038","volume":"10","author":[{"given":"Linying","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7858-9124","authenticated-orcid":false,"given":"Pengxiang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1428-5145","authenticated-orcid":false,"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxuan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oren","family":"Rom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naqash","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0602-1007","authenticated-orcid":false,"given":"Sixue","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuowen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yabing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5161-4705","authenticated-orcid":false,"given":"Jifeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianglin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2357-7825","authenticated-orcid":false,"given":"Y. Eugene","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"2201_CR1","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1161\/CIRCRESAHA.117.311849","volume":"121","author":"DP Leong","year":"2017","unstructured":"Leong, D. P. et al. Reducing the Global Burden of Cardiovascular Disease, Part 2: Prevention and Treatment of Cardiovascular Disease. Circ. Res. 121, 695\u2013710 (2017).","journal-title":"Circ. Res."},{"key":"2201_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/pin.13202","volume":"72","author":"J Fan","year":"2022","unstructured":"Fan, J. & Watanabe, T. Atherosclerosis: Known and unknown. Pathol. Int 72, 151\u2013160 (2022).","journal-title":"Pathol. Int"},{"key":"2201_CR3","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","volume":"592","author":"P Libby","year":"2021","unstructured":"Libby, P. The changing landscape of atherosclerosis. Nature 592, 524\u2013533 (2021).","journal-title":"Nature"},{"key":"2201_CR4","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1161\/ATVBAHA.120.313131","volume":"40","author":"Y Chen","year":"2020","unstructured":"Chen, Y., Zhao, X. & Wu, H. Arterial Stiffness: A Focus on Vascular Calcification and Its Link to Bone Mineralization. Arterioscler. Thromb. Vasc. Biol. 40, 1078\u20131093 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2201_CR5","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1093\/cvr\/cvy007","volume":"114","author":"MOJ Grootaert","year":"2018","unstructured":"Grootaert, M. O. J. et al. Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis. Cardiovasc. Res. 114, 622\u2013634 (2018).","journal-title":"Cardiovasc. Res."},{"key":"2201_CR6","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1093\/eurheartj\/ehu163","volume":"35","author":"P Lanzer","year":"2014","unstructured":"Lanzer, P. et al. Medial vascular calcification revisited: review and perspectives. Eur. Heart J. 35, 1515\u20131525 (2014).","journal-title":"Eur. Heart J."},{"key":"2201_CR7","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1038\/s41588-023-01518-4","volume":"55","author":"M Kavousi","year":"2023","unstructured":"Kavousi, M. et al. Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification. Nat. Genet 55, 1651\u20131664 (2023).","journal-title":"Nat. Genet"},{"key":"2201_CR8","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1001\/jama.2022.13044","volume":"328","author":"CM Mangione","year":"2022","unstructured":"Mangione, C.M. et al. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: USPreventive Services Task Force Recommendation Statement. JAMA 328, 746\u2013753 (2022).","journal-title":"JAMA"},{"key":"2201_CR9","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.jacc.2020.11.079","volume":"77","author":"NS Nurmohamed","year":"2021","unstructured":"Nurmohamed, N. S., Navar, A. M. & Kastelein, J. J. P. New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B: JACC Focus Seminar 1\/4. J. Am. Coll. Cardiol. 77, 1564\u20131575 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2201_CR10","doi-asserted-by":"publisher","first-page":"100962","DOI":"10.1016\/j.arr.2019.100962","volume":"57","author":"Z Yang","year":"2020","unstructured":"Yang, Z. et al. Association of blood lipids, atherosclerosis and statin use with dementia and cognitive impairment after stroke: A systematic review and meta-analysis. Ageing Res. Rev. 57, 100962 (2020).","journal-title":"Ageing Res. Rev."},{"key":"2201_CR11","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1016\/j.jacc.2018.09.051","volume":"72","author":"JD Mitchell","year":"2018","unstructured":"Mitchell, J. D. et al. Impact of Statins on Cardiovascular Outcomes Following Coronary Artery Calcium Scoring. J. Am. Coll. Cardiol. 72, 3233\u20133242 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2201_CR12","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1161\/ATVBAHA.112.301099","volume":"33","author":"MK Osako","year":"2013","unstructured":"Osako, M. K. et al. Cross-talk of receptor activator of nuclear factor-kappaB ligand signaling with renin-angiotensin system in vascular calcification. Arterioscler Thromb. Vasc. Biol. 33, 1287\u20131296 (2013).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"2201_CR13","doi-asserted-by":"publisher","first-page":"102122","DOI":"10.1016\/j.arr.2023.102122","volume":"92","author":"L Roth","year":"2023","unstructured":"Roth, L. et al. Pharmacological modulation of vascular ageing: A review from VascAgeNet. Ageing. Res. Rev. 92, 102122 (2023).","journal-title":"Ageing. Res. Rev."},{"key":"2201_CR14","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41392-022-01153-1","volume":"7","author":"H Chen","year":"2022","unstructured":"Chen, H. et al. Exercise training maintains cardiovascular health: signaling pathways involved and potential therapeutics. Signal. Transduct. Target Ther. 7, 306 (2022).","journal-title":"Signal. Transduct. Target Ther."},{"key":"2201_CR15","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/S0022-2275(20)37904-9","volume":"24","author":"MC Camus","year":"1983","unstructured":"Camus, M. C. et al. Distribution and characterization of the serum lipoproteins and apoproteins in the mouse, Mus musculus. J. Lipid Res. 24, 1210\u20131228 (1983).","journal-title":"J. Lipid Res."},{"key":"2201_CR16","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.tips.2022.06.009","volume":"43","author":"I Ilyas","year":"2022","unstructured":"Ilyas, I. et al. Mouse models of atherosclerosis in translational research. Trends Pharmacol. Sci. 43, 920\u2013939 (2022).","journal-title":"Trends Pharmacol. Sci."},{"key":"2201_CR17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.122.062132","volume":"147","author":"RG Lee","year":"2023","unstructured":"Lee, R. G. et al. Efficacy and Safety of an Investigational Single-Course CRISPR Base-Editing Therapy Targeting PCSK9 in Nonhuman Primate and Mouse Models. Circulation 147, 242\u2013253 (2023).","journal-title":"Circulation"},{"key":"2201_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08936-1","volume":"10","author":"LBL Wittemans","year":"2019","unstructured":"Wittemans, L. B. L. et al. Assessing the causal association of glycine with risk of cardio-metabolic diseases. Nat. Commun. 10, 1060 (2019).","journal-title":"Nat. Commun."},{"key":"2201_CR19","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.tplants.2023.06.012","volume":"28","author":"JA Siqueira","year":"2023","unstructured":"Siqueira, J. A., Zhang, Y., Nunes-Nesi, A., Fernie, A. R. & Araujo, W. L. Beyond photorespiration: the significance of glycine and serine in leaf metabolism. Trends Plant Sci. 28, 1092\u20131094 (2023).","journal-title":"Trends Plant Sci."},{"key":"2201_CR20","doi-asserted-by":"publisher","first-page":"102512","DOI":"10.1016\/j.redox.2022.102512","volume":"58","author":"TS Kou","year":"2022","unstructured":"Kou, T. S. et al. Exogenous glycine promotes oxidation of glutathione and restores sensitivity of bacterial pathogens to serum-induced cell death. Redox Biol. 58, 102512 (2022).","journal-title":"Redox Biol."},{"key":"2201_CR21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.tibs.2014.02.004","volume":"39","author":"I Amelio","year":"2014","unstructured":"Amelio, I., Cutruzzol\u00e1, F., Antonov, A., Agostini, M. & Melino, G. Serine and glycine metabolism in cancer. Trends Biochem. Sci. 39, 191\u2013198 (2014).","journal-title":"Trends Biochem. Sci."},{"key":"2201_CR22","doi-asserted-by":"publisher","first-page":"762564","DOI":"10.3389\/fimmu.2021.762564","volume":"12","author":"Z Gan","year":"2021","unstructured":"Gan, Z. et al. Glycinergic Signaling in Macrophages and Its Application in Macrophage-Associated Diseases. Front. Immunol. 12, 762564 (2021).","journal-title":"Front. Immunol."},{"key":"2201_CR23","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.2337\/dc22-0323","volume":"45","author":"M Xu","year":"2022","unstructured":"Xu, M. et al. SGLT2 Inhibition, Choline Metabolites, and Cardiometabolic Diseases: A Mediation Mendelian Randomization Study. Diab. Care 45, 2718\u20132728 (2022).","journal-title":"Diab. Care"},{"key":"2201_CR24","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.2337\/db15-1272","volume":"65","author":"R Yan-Do","year":"2016","unstructured":"Yan-Do, R. et al. A Glycine-Insulin Autocrine Feedback Loop Enhances Insulin Secretion From Human beta-Cells and Is Impaired in Type 2 Diabetes. Diabetes 65, 2311\u20132321 (2016).","journal-title":"Diabetes"},{"key":"2201_CR25","doi-asserted-by":"publisher","first-page":"102313","DOI":"10.1016\/j.redox.2022.102313","volume":"52","author":"O Rom","year":"2022","unstructured":"Rom, O. et al. Induction of glutathione biosynthesis by glycine-based treatment mitigates atherosclerosis. Redox Biol. 52, 102313 (2022).","journal-title":"Redox Biol."},{"key":"2201_CR26","doi-asserted-by":"crossref","unstructured":"Rom, O. et al. Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome. Sci Transl Med 12(2020).","DOI":"10.1126\/scitranslmed.aaz2841"},{"key":"2201_CR27","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.cmet.2023.03.013","volume":"35","author":"P Qu","year":"2023","unstructured":"Qu, P. et al. DT-109 ameliorates nonalcoholic steatohepatitis in nonhuman primates. Cell Metab. 35, 742\u2013757.e710 (2023).","journal-title":"Cell Metab."},{"key":"2201_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41569-020-0410-z","volume":"18","author":"D Cao","year":"2021","unstructured":"Cao, D. et al. Non-cardiac surgery in patients with coronary artery disease: risk evaluation and periprocedural management. Nat. Rev. Cardiol. 18, 37\u201357 (2021).","journal-title":"Nat. Rev. Cardiol."},{"key":"2201_CR29","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1161\/CIRCRESAHA.122.320334","volume":"130","author":"H Bugger","year":"2022","unstructured":"Bugger, H. et al. Animal Models of Dysregulated Cardiac Metabolism. Circ. Res. 130, 1965\u20131993 (2022).","journal-title":"Circ. Res."},{"key":"2201_CR30","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1161\/CIRCULATIONAHA.111.046755","volume":"125","author":"Y Doring","year":"2012","unstructured":"Doring, Y. et al. Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis. Circulation 125, 1673\u20131683 (2012).","journal-title":"Circulation"},{"key":"2201_CR31","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.redox.2017.12.013","volume":"15","author":"L Zhao","year":"2018","unstructured":"Zhao, L. et al. MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2. Redox Biol. 15, 284\u2013296 (2018).","journal-title":"Redox Biol."},{"key":"2201_CR32","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1161\/CIRCRESAHA.117.312418","volume":"122","author":"J Shen","year":"2018","unstructured":"Shen, J. et al. Regulation of Vascular Calcification by Growth Hormone-Releasing Hormone and Its Agonists. Circ. Res. 122, 1395\u20131408 (2018).","journal-title":"Circ. Res."},{"key":"2201_CR33","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1093\/cvr\/cvad119","volume":"119","author":"A Chen","year":"2023","unstructured":"Chen, A. et al. Sodium-glucose cotransporter 2 inhibitor canagliflozin alleviates vascular calcification through suppression of nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 inflammasome. Cardiovasc. Res. 119, 2368\u20132381 (2023).","journal-title":"Cardiovasc. Res."},{"key":"2201_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0960-0760(03)00235-8","volume":"85","author":"O Barbier","year":"2003","unstructured":"Barbier, O. & Belanger, A. The cynomolgus monkey (Macaca fascicularis) is the best animal model for the study of steroid glucuronidation. J. Steroid Biochem Mol. Biol. 85, 235\u2013245 (2003).","journal-title":"J. Steroid Biochem Mol. Biol."},{"key":"2201_CR35","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1126\/science.2360042","volume":"248","author":"DP Rosenberg","year":"1990","unstructured":"Rosenberg, D. P. Cynomolgus monkeys. Science 248, 1473 (1990).","journal-title":"Science"},{"key":"2201_CR36","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1046\/j.1523-1755.2001.060002472.x","volume":"60","author":"MR Davies","year":"2001","unstructured":"Davies, M. R. & Hruska, K. A. Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Kidney Int 60, 472\u2013479 (2001).","journal-title":"Kidney Int"},{"key":"2201_CR37","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1161\/ATVBAHA.116.306256","volume":"37","author":"K Yahagi","year":"2017","unstructured":"Yahagi, K. et al. Pathology of Human Coronary and Carotid Artery Atherosclerosis and Vascular Calcification in Diabetes Mellitus. Arterioscler. Thromb. Vasc. Biol. 37, 191\u2013204 (2017).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2201_CR38","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1177\/2047487314529351","volume":"22","author":"GF Svingen","year":"2015","unstructured":"Svingen, G. F. et al. Elevated plasma dimethylglycine is a risk marker of mortality in patients with coronary heart disease. Eur. J. Prev. Cardiol. 22, 743\u2013752 (2015).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"2201_CR39","doi-asserted-by":"publisher","first-page":"e002621","DOI":"10.1161\/JAHA.115.002621","volume":"5","author":"Y Ding","year":"2015","unstructured":"Ding, Y. et al. Plasma Glycine and Risk of Acute Myocardial Infarction in Patients With Suspected Stable Angina Pectoris. J. Am. Heart Assoc. 5, e002621 (2015).","journal-title":"J. Am. Heart Assoc."},{"key":"2201_CR40","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.freeradbiomed.2021.06.020","volume":"172","author":"X Yang","year":"2021","unstructured":"Yang, X. et al. Up-regulation of heme oxygenase-1 by celastrol alleviates oxidative stress and vascular calcification in chronic kidney disease. Free Radic. Biol. Med. 172, 530\u2013540 (2021).","journal-title":"Free Radic. Biol. Med."},{"key":"2201_CR41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.arr.2007.09.001","volume":"6","author":"JJ Li","year":"2007","unstructured":"Li, J. J. et al. The role of inflammation in coronary artery calcification. Ageing Res. Rev. 6, 263\u2013270 (2007).","journal-title":"Ageing Res. Rev."},{"key":"2201_CR42","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1007\/s00259-016-3608-x","volume":"44","author":"T Nakahara","year":"2017","unstructured":"Nakahara, T. & Strauss, H. W. From inflammation to calcification in atherosclerosis. Eur. J. Nucl. Med. Mol. Imaging 44, 858\u2013860 (2017).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"2201_CR43","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross, R. Atherosclerosis\u2013an inflammatory disease. N. Engl. J. Med 340, 115\u2013126 (1999).","journal-title":"N. Engl. J. Med"},{"key":"2201_CR44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.atherosclerosis.2022.03.005","volume":"347","author":"J Lu","year":"2022","unstructured":"Lu, J. et al. Blocking the NLRP3 inflammasome reduces osteogenic calcification and M1 macrophage polarization in a mouse model of calcified aortic valve stenosis. Atherosclerosis 347, 28\u201338 (2022).","journal-title":"Atherosclerosis"},{"key":"2201_CR45","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1016\/j.ijcard.2013.01.211","volume":"168","author":"C Wen","year":"2013","unstructured":"Wen, C. et al. Nalp3 inflammasome is activated and required for vascular smooth muscle cell calcification. Int. J. Cardiol. 168, 2242\u20132247 (2013).","journal-title":"Int. J. Cardiol."},{"key":"2201_CR46","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000525089","volume":"15","author":"F He","year":"2023","unstructured":"He, F. et al. Slc6a13 Deficiency Attenuates Pasteurella multocida Infection-Induced Inflammation via Glycine-Inflammasome Signaling. J. Innate Immun. 15, 107\u2013121 (2023).","journal-title":"J. Innate Immun."},{"key":"2201_CR47","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.cardiores.2004.10.022","volume":"65","author":"T Koike","year":"2005","unstructured":"Koike, T. et al. Enhanced aortic atherosclerosis in transgenic Watanabe heritable hyperlipidemic rabbits expressing lipoprotein lipase. Cardiovasc. Res. 65, 524\u2013534 (2005).","journal-title":"Cardiovasc. Res."},{"key":"2201_CR48","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1161\/ATVBAHA.117.309114","volume":"37","author":"J Zhang","year":"2017","unstructured":"Zhang, J. et al. Deficiency of Cholesteryl Ester Transfer Protein Protects Against Atherosclerosis in Rabbits. Arterioscler. Thromb. Vasc. Biol. 37, 1068\u20131075 (2017).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2201_CR49","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.kint.2022.07.034","volume":"102","author":"Y Ye","year":"2022","unstructured":"Ye, Y. et al. Repression of the antiporter SLC7A11\/glutathione\/glutathione peroxidase 4 axis drives ferroptosis of vascular smooth muscle cells to facilitate vascular calcification. Kidney Int 102, 1259\u20131275 (2022).","journal-title":"Kidney Int"},{"key":"2201_CR50","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2022.02.007","volume":"346","author":"PW Wang","year":"2022","unstructured":"Wang, P. W. et al. Irisin alleviates vascular calcification by inhibiting VSMC osteoblastic transformation and mitochondria dysfunction via AMPK\/Drp1 signaling pathway in chronic kidney disease. Atherosclerosis 346, 36\u201345 (2022).","journal-title":"Atherosclerosis"},{"key":"2201_CR51","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1161\/ATVBAHA.117.309672","volume":"37","author":"L Bai","year":"2017","unstructured":"Bai, L. et al. Mediator 1 Is Atherosclerosis Protective by Regulating Macrophage Polarization. Arterioscler Thromb. Vasc. Biol. 37, 1470\u20131481 (2017).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"2201_CR52","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/CIRCRESAHA.120.317361","volume":"128","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. Variants of Focal Adhesion Scaffold Genes Cause Thoracic Aortic Aneurysm. Circ. Res. 128, 8\u201323 (2021).","journal-title":"Circ. Res."},{"key":"2201_CR53","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.ajpath.2022.03.013","volume":"192","author":"M Fatima","year":"2022","unstructured":"Fatima, M. et al. MED1 Deficiency in Macrophages Aggravates Isoproterenol-Induced Cardiac Fibrosis in Mice. Am. J. Pathol. 192, 1016\u20131027 (2022).","journal-title":"Am. J. Pathol."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02201-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02201-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02201-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T04:56:49Z","timestamp":1744001809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02201-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2201"],"URL":"https:\/\/doi.org\/10.1038\/s41392-025-02201-2","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"4 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ying Zhao, Oren Rom, Jifeng Zhang, and Y. Eugene Chen are inventors of the patent application (Tri-peptides and treatment of metabolic, cardiovascular, and inflammatory disorders: PCT\/US2019\/046052). Y. Eugene Chen is the founder of Diapin Therapeutics, Inc. and provided DT-109 for the current study. All other authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"122"}}